Julie is an applied health economist and evaluation leader specializing in Medicare payment and delivery reform, advanced econometric analysis, and mixed‑methods evaluation. At NORC, she directs complex federal health policy evaluations and provides senior methodological guidance across projects involving Medicare claims analysis, quantitative study design, and cross‑agency policy advising. Julie brings more than two decades of experience shaping federal health programs through rigorous impact evaluation, translating complex analytic findings for policymakers, and leading large, multidisciplinary quantitative teams. Her expertise spans Medicare payment models, econometric modeling, evaluation design, rapid‑response analytics, and strategic guidance for federal partners. She is recognized for her ability to ensure methodological integrity, strengthen analytic capacity, and communicate actionable insights to senior decision-makers across CMS, CMMI, and broader HHS programs.

Julie’s expertise is reflected in her leadership of large-scale Medicare evaluations and her role in shaping federal program design. She directed multiple flagship CMS Innovation Center evaluations—BPCI Advanced, CJR, and BPCI—that integrated Medicare claims, qualitative research, and advanced modeling to assess model performance and inform program redesign. Her teams’ findings directly influenced updates to target pricing, selection-bias mitigation approaches, and the development of the Transforming Episode Accountability Model (TEAM). Julie also led mixed-methods evaluation frameworks that combined claims, surveys, interviews, and rapid‑response analyses to assess spending, utilization, and beneficiary experience. Across her projects, she strengthened client partnerships by consistently delivering high-quality, policy-relevant products, earning multiple “Exceptional” CPARS ratings for analytic rigor, communication, and responsiveness.

Before joining NORC, Julie held senior roles advising federal health policy at Mathematica, MedPAC, and the Congressional Budget Office. As a Senior Fellow and FDA Area Director at Mathematica, she shaped enterprise strategy, guided evaluation design across federal contracts, and led major initiatives assessing CMMI’s model portfolio. At MedPAC, Julie authored chapters for Reports to Congress on Medicare spending, payment policy, and beneficiary trends, presenting findings in public sessions. During her decade at CBO, she developed models assessing provider capacity under Medicaid expansion, analyzed drug pricing across federal programs, and produced influential reports on vaccines and pandemic preparedness used by congressional committees. Earlier in her career, she led quantitative modeling in energy markets at Charles River Associates and supported econometric litigation work at Putnam, Hayes & Bartlett, building the analytical foundation that informs her federal health policy leadership today.